PNEUMOVAS study results suggest AAV pts on RTX showed improved S. Pneumoniae ab response with double dose of PCV13 at day 0 and day 7 followed by a single dose of PPV23 at M5. More data needed on this updated, clinical strategy. Abs L16 #ACR22 @RheumNow https://t.co/m71VQMGZ68